Clinical Trials Directory

Trials / Completed

CompletedNCT03516643

Extracorporeal Shockwave Myocardial Revascularization in Refractory Angina

Improving Myocardial Perfusion in Refractory Angina. Extracorporeal Shockwave Myocardial Revascularization in a Large Prospective Cohort

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
122 (actual)
Sponsor
University of Turin, Italy · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This is a prospective cohort study to examine the efficacy of ESMR application in patients with refractory angina despite optimal medical therapy, not suitable for further PCI or CABG. Characteristics such as angina class scores (CCS class score), nitroglycerin consumption and hospitalization were compared at baseline and 1, 6 and 12 months after ESMR therapy. The effect on cardiac perfusion was assessed at 6 months.

Conditions

Interventions

TypeNameDescription
OTHERExtracorporeal Shockwave Myocardial Revascularizationextracorporeal shockwave in ischemic area evaluated by SPECT

Timeline

Start date
2009-01-01
Primary completion
2010-01-01
Completion
2018-04-01
First posted
2018-05-04
Last updated
2018-05-04

Source: ClinicalTrials.gov record NCT03516643. Inclusion in this directory is not an endorsement.

Extracorporeal Shockwave Myocardial Revascularization in Refractory Angina (NCT03516643) · Clinical Trials Directory